-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

Benzinga·09/25/2026 16:53:07
Diffusion vocale
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.